West Pharmaceutical Services, Inc.
New York Stock ExchangeTotal Valuation
West Pharmaceutical Services, Inc. carries a market capitalization of 22.35B, placing it among publicly traded companies globally. Its enterprise value stands at 17.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 22.35B |
| Enterprise Value | 17.88B |
Share Statistics
West Pharmaceutical Services, Inc. currently has 70.90M shares outstanding.
| Shares Outstanding | 70.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
West Pharmaceutical Services, Inc. trades at a trailing price-to-earnings ratio of 33.33. The price-to-sales ratio is 5.62, and the price-to-book ratio stands at 4.02.
| PE Ratio | 33.33 |
| PS Ratio | 5.62 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 6.29 |
| P/FCF Ratio | 25.42 |
| P/OCF Ratio | 25.29 |
Enterprise Valuation
On an enterprise value basis, West Pharmaceutical Services, Inc. trades at an EV/EBITDA multiple of 20.65 and an EV/FCF ratio of 24.95. The EV/Sales ratio of 5.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.93 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.55 |
| EV / EBITDA | 20.65 |
| EV / EBIT | 25.93 |
| EV / FCF | 24.95 |
Financial Position
West Pharmaceutical Services, Inc. maintains a current ratio of 2.71, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.57, indicating elevated leverage, while an interest coverage ratio of 433.10 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.71 |
| Quick Ratio | 1.79 |
| Debt / Equity | 10.57 |
| Debt / EBITDA | 0.37 |
| Interest Coverage | 433.10 |
Financial Efficiency
West Pharmaceutical Services, Inc. posts a return on equity of 12.70 and a return on invested capital of 17.00.
| Return on Equity (ROE) | 12.70 |
| Return on Assets (ROA) | 14.05 |
| Return on Invested Capital (ROIC) | 17.00 |
| Return on Capital Employed (ROCE) | 11.88 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.88 |
Taxes
Over the trailing twelve months, West Pharmaceutical Services, Inc. has paid 142.20M in income taxes, reflecting an effective tax rate of 21.21.
| Income Tax | 142.20M |
| Effective Tax Rate | 21.21 |
Stock Price Statistics
West Pharmaceutical Services, Inc.'s stock has gained approximately 49.60507% over the past 52 weeks. The 50-day moving average sits at 287.07, while the 200-day moving average is 266.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | 49.60507% |
| 50-Day Moving Average | 287.07 |
| 200-Day Moving Average | 266.86 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, West Pharmaceutical Services, Inc. generated 3.22B in revenue and converted that into 542.70M in net income, yielding earnings per share of 7.48. EBITDA reached 866.20M, while operating income came in at 689.60M.
| Revenue | 3.22B |
| Gross Profit | 1.17B |
| Operating Income | 689.60M |
| Pretax Income | 670.50M |
| Net Income | 542.70M |
| EBITDA | 866.20M |
| EBIT | 689.60M |
| Earnings Per Share (EPS) | 7.48 |
Balance Sheet
West Pharmaceutical Services, Inc. holds 521.40M in cash and equivalents against 316.20M in total debt, resulting in a net debt position of -318.60M. Total book value stands at 4.49B, with working capital of 1.15B providing operational flexibility.
| Cash & Cash Equivalents | 521.40M |
| Total Debt | 316.20M |
| Net Debt | -318.60M |
| Equity (Book Value) | 4.49B |
| Book Value Per Share | 62.28 |
| Working Capital | 1.15B |
Cash Flow
West Pharmaceutical Services, Inc. produced 715.30M in operating cash flow over the past twelve months.
| Operating Cash Flow | 715.30M |
| Capital Expenditures | N/A |
| Free Cash Flow | 715.30M |
| FCF Per Share | 9.91 |
Margins
West Pharmaceutical Services, Inc. operates with a gross margin of 36.28, reflecting its pricing power and cost economics. The operating margin of 21.41 and net profit margin of 16.85 provide insight into operational efficiency.
| Gross Margin | 36.28 |
| Operating Margin | 21.41 |
| Pretax Margin | 20.82 |
| Profit Margin | 16.85 |
| EBITDA Margin | 26.89 |
Dividends & Yields
The company's payout ratio of 11.39 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.86 |
| Dividend Yield | N/A |
| Payout Ratio | 11.39 |
| Shareholder Yield | 1.92 |
| FCF Yield | 3.93 |
Stock Splits
West Pharmaceutical Services, Inc.'s most recent stock split took place on September 27, 2013 with a 1:2 split ratio.
| Last Split Date | 9/27/2013 |
| Split Ratio | 1:2 |
Scores
West Pharmaceutical Services, Inc. posts an Altman Z-Score of 12.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.99 |